Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension
Objective: To describe adverse behavioral symptoms attributed to droxidopa therapy for neurogenic orthostatic hypotension (nOH). Background: Droxidopa, a norepinephrine (NE) precursor, improves symptoms of neurogenic…Affective theory of mind in Parkinson’s disease
Objective: The aim of this study is to assess the hypothesis that patients with PD may show difficulties in tasks related to affective theory of…Correlation between self-perceived balance confidence, postural control, gait and quality of life of individuals with Parkinson’s disease
Objective: To examine the association of self-perceived balance confidence level with postural control, gait and the quality of life in Parkinson's disease (PD) people on…Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)
Objective: To assess the clinimetric properties of the Hebrew version of the MDS-UPDRS. Background: The Unified Parkinson's disease Rating Scale (UPDRS) is a rating scale…Assessment of oral hygiene status before and after the use of powered tooth brush in patients with Parkinson’s diseases
Objective: The objective of this study was to assess the oral hygiene status, gingival status and also the Oral health related quality of life (OHRQoL)…Participant feedback in the PREDICT-PD study
Objective: To explore the underlying motivation behind participation in PREDICT-PD and whether this had an influence on later drop out from the study. Background: The…Tear fluid as potential biomarker for the diagnosis of Parkinson’s disease
Objective: This study compares tear fluid proteome in patients with idiopathic Parkinson´s disease (PD) and age-matched healthy controls (HC) to characterize disease-related proteomic changes and…Effects of exercise intervention on balance and gait performance, and balance confidence in people with Parkinson’s disease – A meta-analysis
Objective: To examine the short- and long-term effects of exercise intervention on enhancing balance, and gait performance, and balance confidence in Parkinson's disease (PD) population,…Nilotinib improves motor skills, cognition and autonomic function in open-label phase I clinical trial in Parkinson’s disease with dementia and Lewy body dementia
Objective: Nilotinib, a tyrosine kinase inhibitor (TKI) was examined with the aim of showing its effect on safety comparing a lower dose of 150mg (N=6)…The NIC-PD-study –Baseline data of a randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson’s disease in Germany and the USA
Objective: The primary endpoint of clinical progression is measured by change in the total UPDRS score between baseline and 1) after 52 weeks of study…
- « Previous Page
- 1
- …
- 359
- 360
- 361
- 362
- 363
- …
- 425
- Next Page »